Mitochondria-immunometabolism in sepsis-induced liver injury: mechanisms, biomarkers, and therapeutic opportunities.

Wang Y, Zhao P.

Open source

DOI
10.3389/fcimb.2026.1866390
Published
2026-09-02
Container
Front Cell Infect Microbiol
Publisher
Not recorded
Open access
no

Credibility signals

uncertain Score 51/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fcimb.2026.1866390,
  title = {Mitochondria-immunometabolism in sepsis-induced liver injury: mechanisms, biomarkers, and therapeutic opportunities.},
  author = {Wang Y and  Zhao P.},
  year = {2026},
  journal = {Front Cell Infect Microbiol},
  doi = {10.3389/fcimb.2026.1866390},
  url = {https://doi.org/10.3389/fcimb.2026.1866390}
}

RIS

TY  - JOUR
TI  - Mitochondria-immunometabolism in sepsis-induced liver injury: mechanisms, biomarkers, and therapeutic opportunities.
AU  - Wang Y
AU  -  Zhao P.
PY  - 2026
JO  - Front Cell Infect Microbiol
DO  - 10.3389/fcimb.2026.1866390
UR  - https://doi.org/10.3389/fcimb.2026.1866390
ER  - 

APA

Y, W., & P., Z. (2026). Mitochondria-immunometabolism in sepsis-induced liver injury: mechanisms, biomarkers, and therapeutic opportunities.. Front Cell Infect Microbiol. https://doi.org/10.3389/fcimb.2026.1866390

Source records